Quick Answer
GYRE THERAPEUTICS, INC. reported Total Assets of $166.13 million for the year ending 2025.
- GYRE THERAPEUTICS, INC. showed an increase of +32.5% in Total Assets from 2024 to 2025.
- This data is from GYRE THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $300.02 million | Q3 2011: $279.74 million | Q1 2012: $231.10 million | Q2 2012: $212.62 million | Q3 2012: $203.50 million | Q1 2013: $178.75 million | Q2 2013: $167.49 million | Q3 2013: $157.85 million | Q1 2014: $134.11 million | Q2 2014: $124.52 million | Q3 2014: $116.12 million | Q1 2015: $107.14 million | Q2 2015: $101.17 million | Q3 2015: $74.51 million | Q1 2016: $61.54 million | Q2 2016: $57.22 million | Q3 2016: $51.62 million | Q1 2017: $29.06 million | Q2 2017: $39.63 million | Q3 2017: $34.39 million | Q1 2018: $145.89 million | Q2 2018: $139.54 million | Q3 2018: $133.42 million | Q1 2019: $111.87 million | Q2 2019: $100.87 million | Q3 2019: $91.79 million | Q1 2020: $110.56 million | Q2 2020: $123.68 million | Q3 2020: $111.80 million | Q1 2021: $119.08 million | Q2 2021: $101.79 million | Q3 2021: $78.54 million | Q1 2022: $40.27 million | Q2 2022: $83.37 million | Q3 2022: $31.02 million | Q1 2023: $18.75 million | Q2 2023: $12.39 million | Q3 2023: $9.96 million | Q1 2024: $122.01 million | Q2 2024: $120.93 million | Q3 2024: $125.24 million | Q1 2025: $129.79 million | Q2 2025: $152.65 million | Q3 2025: $159.38 million.
- Over the full 16 years of available data (2010 to 2025), GYRE THERAPEUTICS, INC.'s Total Assets has declined by 36.8%.
- Historical annual values: Fiscal year 2025: $166.13 million | Fiscal year 2024: $125.41 million | Fiscal year 2023: $116.54 million | Fiscal year 2022: $84.75 million | Fiscal year 2021: $55.66 million | Fiscal year 2020: $94.85 million | Fiscal year 2019: $98.55 million | Fiscal year 2018: $124.92 million | Fiscal year 2017: $39.51 million | Fiscal year 2016: $38.09 million | Fiscal year 2015: $69.52 million | Fiscal year 2014: $2.98 million | Fiscal year 2013: $145.87 million | Fiscal year 2012: $189.58 million | Fiscal year 2011: $258.13 million | Fiscal year 2010: $262.79 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: